Adamas Wins FDA OK for the First and Only Drug for Parkinson's Dyskinesia Drug Post author:Sam Post published:August 24, 2017 Post category:BioPharma August 25, 2017By Mark Terry, BioSpace.com… Source: BioSpace You Might Also Like Synergy Pharma To Highlight New Data For TRULANCE (Plecanatide) At April 30, 2017 AstraZeneca PLC Forges $400 Million Parkinson's R&D Deal With Takeda August 28, 2017 Feds Accuse 'Greedy' Pharmakon Execs of Selling Drugs That Sickened Babies June 22, 2017
